These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


317 related items for PubMed ID: 19147545

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Wwox suppresses prostate cancer cell growth through modulation of ErbB2-mediated androgen receptor signaling.
    Qin HR, Iliopoulos D, Nakamura T, Costinean S, Volinia S, Druck T, Sun J, Okumura H, Huebner K.
    Mol Cancer Res; 2007 Sep; 5(9):957-65. PubMed ID: 17704139
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
    You Z, Shi XB, DuRaine G, Haudenschild D, Tepper CG, Lo SH, Gandour-Edwards R, de Vere White RW, Reddi AH.
    Cancer Res; 2006 Jan 01; 66(1):175-83. PubMed ID: 16397230
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.
    Tsui KH, Lin YF, Chen YH, Chang PL, Juang HH.
    J Androl; 2011 Jan 01; 32(4):383-93. PubMed ID: 21051589
    [Abstract] [Full Text] [Related]

  • 25. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.
    Péant B, Diallo JS, Lessard L, Delvoye N, Le Page C, Saad F, Mes-Masson AM.
    Mol Cancer Res; 2007 Jan 01; 5(1):87-94. PubMed ID: 17259348
    [Abstract] [Full Text] [Related]

  • 26. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S, Roth CP, Wasson LM, Vishwanatha JK.
    Prostate; 2007 Oct 01; 67(14):1550-64. PubMed ID: 17705178
    [Abstract] [Full Text] [Related]

  • 27. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.
    Meng TC, Lee MS, Lin MF.
    Oncogene; 2000 May 18; 19(22):2664-77. PubMed ID: 10851066
    [Abstract] [Full Text] [Related]

  • 28. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
    Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV.
    Clin Cancer Res; 2006 Sep 01; 12(17):5055-63. PubMed ID: 16951221
    [Abstract] [Full Text] [Related]

  • 29. PC-1/PrLZ contributes to malignant progression in prostate cancer.
    Zhang H, Wang J, Pang B, Liang RX, Li S, Huang PT, Wang R, Chung LW, Zhau HE, Huang C, Zhou JG.
    Cancer Res; 2007 Sep 15; 67(18):8906-13. PubMed ID: 17875733
    [Abstract] [Full Text] [Related]

  • 30. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
    Bauer K, Kretzschmar AK, Cvijic H, Blumert C, Löffler D, Brocke-Heidrich K, Schiene-Fischer C, Fischer G, Sinz A, Clevenger CV, Horn F.
    Oncogene; 2009 Aug 06; 28(31):2784-95. PubMed ID: 19503092
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Regulation of STAT3-mediated signaling by LMW-DSP2.
    Sekine Y, Tsuji S, Ikeda O, Sato N, Aoki N, Aoyama K, Sugiyama K, Matsuda T.
    Oncogene; 2006 Sep 21; 25(42):5801-6. PubMed ID: 16636663
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.
    Squarize CH, Castilho RM, Sriuranpong V, Pinto DS, Gutkind JS.
    Neoplasia; 2006 Sep 21; 8(9):733-46. PubMed ID: 16984731
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells.
    Konnikova L, Simeone MC, Kruger MM, Kotecki M, Cochran BH.
    Cancer Res; 2005 Aug 01; 65(15):6516-20. PubMed ID: 16061629
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.